Biotechnology
The Biotechnology industry has a total of 598 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.38 billion.
Market Cap
1.11T
Revenue
105.38B
Profits
-41.4B
PE Ratio
n/a
Profit Margin
-39.28%
Dividend Yield
0.04%
598 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 119.22B | -1.22% | 1,190,083 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.07B | -1.07% | 1,317,887 | 14.34B |
| 3 | ARGX | argenx SE | 51.17B | -0.85% | 292,615 | 3.68B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.66B | -2.52% | 1,648,390 | 3.21B |
| 5 | ONC | BeOne Medicines AG | 37.67B | -2.75% | 296,847 | 4.97B |
| 6 | INSM | Insmed Incorporated | 33.46B | -0.60% | 2,686,018 | 447.02M |
| 7 | BNTX | BioNTech SE | 28.54B | -2.59% | 872,191 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 24.06B | 2.01% | 3,466,548 | 2.35B |
| 9 | GMAB | Genmab A/S | 19.81B | -2.16% | 1,415,634 | 3.85B |
| 10 | INCY | Incyte Corporation | 19.65B | -1.00% | 1,988,870 | 4.81B |
| 11 | RVMD | Revolution Medicines, Inc. | 18.74B | -1.27% | 2,090,110 | - |
| 12 | MRNA | Moderna, Inc. | 17.22B | -5.95% | 10,957,188 | 2.23B |
| 13 | ROIV | Roivant Sciences Ltd. | 15.04B | -1.82% | 3,461,682 | 20.33M |
| 14 | BBIO | BridgeBio Pharma, Inc. | 14.89B | -2.31% | 2,344,722 | 353.78M |
| 15 | ASND | Ascendis Pharma A/S | 13.88B | 0.96% | 327,330 | 758.59M |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 13.39B | -1.44% | 2,507,230 | 966.96M |
| 17 | SMMT | Summit Therapeutics Inc. | 11.17B | -5.97% | 4,142,211 | - |
| 18 | EXEL | Exelixis, Inc. | 11.13B | -2.18% | 3,436,169 | 2.29B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.11B | -1.09% | 668,552 | 740.64M |
| 20 | RNA | Avidity Biosciences, Inc. | 10.93B | - | 1,235,125 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.86B | -0.79% | 1,879,015 | 3.09B |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 10.00B | 0.31% | 1,291,980 | 4.16B |
| 23 | TECH | Bio-Techne Corporation | 9.99B | 0.17% | 2,485,744 | 1.22B |
| 24 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.71B | 0.30% | 3,756,806 | 829.45M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 9.29B | -0.55% | 745,829 | 561.26M |
| 26 | ABVX | ABIVAX Société Anonyme | 8.77B | -2.10% | 633,012 | 6.23M |
| 27 | PRAX | Praxis Precision Medicines, Inc. | 8.71B | -0.09% | 658,977 | 7.46M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.43B | -2.22% | 2,044,207 | 1.24B |
| 29 | KRYS | Krystal Biotech, Inc. | 8.10B | -0.04% | 270,863 | 373.16M |
| 30 | NUVL | Nuvalent, Inc. | 8.00B | 0.53% | 506,495 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 7.73B | -3.67% | 1,932,972 | 87.21M |
| 32 | PCVX | Vaxcyte, Inc. | 7.01B | 1.42% | 5,275,293 | - |
| 33 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.84B | -1.07% | 667,315 | 174.33M |
| 34 | CAI | Caris Life Sciences, Inc. | 6.53B | -8.10% | 2,852,388 | 649.06M |
| 35 | BLTE | Belite Bio, Inc | 6.34B | -0.01% | 193,504 | - |
| 36 | MIRM | Mirum Pharmaceuticals, Inc. | 6.18B | 0.29% | 805,332 | 471.79M |
| 37 | IBRX | ImmunityBio, Inc. | 6.16B | 5.75% | 29,537,843 | 82.56M |
| 38 | GPCR | Structure Therapeutics Inc. | 6.12B | 1.49% | 789,108 | - |
| 39 | PTCT | PTC Therapeutics, Inc. | 6.06B | -1.18% | 1,405,674 | 1.78B |
| 40 | KYMR | Kymera Therapeutics, Inc. | 5.82B | -1.65% | 927,598 | 43.74M |
| 41 | COGT | Cogent Biosciences, Inc. | 5.46B | -4.62% | 1,594,667 | - |
| 42 | IMVT | Immunovant, Inc. | 5.27B | -1.70% | 1,824,772 | - |
| 43 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.12B | -3.74% | 1,214,538 | 1.54M |
| 44 | PTGX | Protagonist Therapeutics, Inc. | 5.11B | 2.60% | 1,174,009 | 209.22M |
| 45 | CELC | Celcuity Inc. | 5.06B | -2.41% | 683,173 | - |
| 46 | CRSP | CRISPR Therapeutics AG | 4.76B | -6.35% | 2,243,457 | 38.34M |
| 47 | SRRK | Scholar Rock Holding Corporation | 4.52B | -1.29% | 916,181 | - |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.42B | -6.39% | 1,893,603 | - |
| 49 | FOLD | Amicus Therapeutics, Inc. | 4.42B | 0.14% | 4,742,869 | 598.70M |
| 50 | TGTX | TG Therapeutics, Inc. | 4.30B | -1.90% | 1,814,191 | 531.90M |
| 51 | ACAD | ACADIA Pharmaceuticals Inc. | 4.25B | -2.22% | 1,210,235 | 1.05B |
| 52 | CGON | CG Oncology, Inc. | 4.20B | -2.56% | 777,972 | 2.17M |
| 53 | CORT | Corcept Therapeutics Incorporated | 4.19B | -10.63% | 5,067,467 | 741.17M |
| 54 | ADMA | ADMA Biologics, Inc. | 4.12B | 1.70% | 3,267,806 | 488.56M |
| 55 | ACLX | Arcellx, Inc. | 3.95B | 0.07% | 841,909 | 35.90M |
| 56 | LGND | Ligand Pharmaceuticals Incorporated | 3.78B | -1.57% | 184,861 | 251.23M |
| 57 | TERN | Terns Pharmaceuticals, Inc. | 3.76B | 1.17% | 2,865,508 | - |
| 58 | LQDA | Liquidia Corporation | 3.69B | -1.56% | 1,529,556 | 69.22M |
| 59 | CNTA | Centessa Pharmaceuticals plc | 3.59B | -1.29% | 958,537 | 15.00M |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.53B | -1.02% | 371,124 | 35.24M |
| 61 | DNLI | Denali Therapeutics Inc. | 3.39B | 0.69% | 2,743,840 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.28B | -3.97% | 3,532,333 | - |
| 63 | ERAS | Erasca, Inc. | 3.25B | 1.94% | 4,565,266 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.23B | -1.24% | 2,981,759 | 909.05M |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.17B | -1.80% | 612,530 | 7.50M |
| 66 | VRDN | Viridian Therapeutics, Inc. | 3.15B | -1.70% | 2,373,587 | 70.79M |
| 67 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | -1.40% | 929,187 | 317.93M |
| 68 | VERA | Vera Therapeutics, Inc. | 3.07B | -3.87% | 1,254,453 | - |
| 69 | ALMS | Alumis Inc. | 3.06B | -8.68% | 1,889,876 | 22.12M |
| 70 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.99B | -1.14% | 972,246 | 578.20M |
| 71 | EWTX | Edgewise Therapeutics, Inc. | 2.98B | -2.15% | 839,346 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.95B | 0.06% | 2,446,521 | - |
| 73 | IRON | Disc Medicine, Inc. | 2.92B | -1.57% | 471,934 | - |
| 74 | APLS | Apellis Pharmaceuticals, Inc. | 2.86B | -2.04% | 18,557,834 | 1.02B |
| 75 | ADPT | Adaptive Biotechnologies Corporation | 2.82B | 0.71% | 1,882,412 | 252.75M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.82B | -2.42% | 823,500 | 214.83M |
| 77 | TVTX | Travere Therapeutics, Inc. | 2.78B | -2.81% | 2,000,539 | 435.83M |
| 78 | TARS | Tarsus Pharmaceuticals, Inc. | 2.74B | -1.78% | 444,743 | 366.10M |
| 79 | BEAM | Beam Therapeutics Inc. | 2.73B | -5.70% | 1,668,698 | 55.70M |
| 80 | IMNM | Immunome, Inc. | 2.72B | -1.79% | 1,359,069 | 9.68M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.60B | -3.44% | 1,275,062 | 240.00M |
| 82 | TLX | Telix Pharmaceuticals Limited | 2.50B | -6.06% | 129,617 | 664.23M |
| 83 | SYRE | Spyre Therapeutics, Inc. | 2.48B | -4.76% | 535,729 | - |
| 84 | MLYS | Mineralys Therapeutics, Inc. | 2.44B | -3.74% | 894,159 | - |
| 85 | WVE | Wave Life Sciences Ltd. | 2.37B | -0.54% | 2,327,885 | 109.23M |
| 86 | RARE | Ultragenyx Pharmaceutical Inc. | 2.32B | -0.82% | 3,775,604 | 630.60M |
| 87 | DNTH | Dianthus Therapeutics, Inc. | 2.29B | 0.06% | 2,827,485 | 3.08M |
| 88 | MESO | Mesoblast Limited | 2.28B | -3.95% | 242,240 | 17.20M |
| 89 | AAPG | Ascentage Pharma Group International | 2.27B | -3.28% | 9,587 | 54.52M |
| 90 | GLPG | Galapagos NV | 2.23B | -0.73% | 95,515 | 336.64M |
| 91 | RXRX | Recursion Pharmaceuticals, Inc. | 2.18B | -3.01% | 19,769,106 | 43.69M |
| 92 | SRPT | Sarepta Therapeutics, Inc. | 2.13B | -4.24% | 3,121,955 | 2.41B |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | -0.92% | 444,831 | 825.94M |
| 94 | MAZE | Maze Therapeutics, Inc. | 2.10B | -3.16% | 479,638 | 2.50M |
| 95 | SLNO | Soleno Therapeutics, Inc. | 2.07B | -4.91% | 3,272,771 | 98.68M |
| 96 | OLMA | Olema Pharmaceuticals, Inc. | 2.02B | -1.30% | 1,210,586 | - |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.95B | -8.14% | 7,115,009 | 55.78M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.92B | -0.82% | 910,923 | 265.81M |
| 99 | SION | Sionna Therapeutics, Inc. | 1.89B | -0.42% | 229,470 | - |
| 100 | ARDX | Ardelyx, Inc. | 1.87B | -2.04% | 2,696,776 | 398.23M |
| 101 | ZLAB | Zai Lab Limited | 1.85B | -3.77% | 613,057 | 441.63M |
| 102 | VCEL | Vericel Corporation | 1.82B | -1.42% | 512,895 | 258.72M |
| 103 | NUVB | Nuvation Bio Inc. | 1.80B | -1.87% | 4,297,797 | 26.75M |
| 104 | MNKD | MannKind Corporation | 1.77B | -0.17% | 4,275,160 | 313.79M |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 1.77B | -1.36% | 1,996,316 | 111.30M |
| 106 | PHVS | Pharvaris N.V. | 1.76B | -2.66% | 122,938 | - |
| 107 | CRVS | Corvus Pharmaceuticals, Inc. | 1.73B | -1.15% | 2,425,537 | - |
| 108 | STOK | Stoke Therapeutics, Inc. | 1.73B | -2.25% | 557,692 | 205.63M |
| 109 | NRIX | Nurix Therapeutics, Inc. | 1.70B | -6.08% | 1,560,974 | 83.98M |
| 110 | ZYME | Zymeworks Inc. | 1.69B | 0.67% | 560,163 | 134.48M |
| 111 | UPB | Upstream Bio, Inc. | 1.68B | 0.45% | 667,376 | 2.80M |
| 112 | RAPT | RAPT Therapeutics, Inc. | 1.67B | 0.09% | 2,082,215 | - |
| 113 | DFTX | Definium Therapeutics, Inc. | 1.66B | -2.09% | 1,657,321 | - |
| 114 | ORKA | Oruka Therapeutics, Inc. | 1.66B | -2.92% | 378,250 | - |
| 115 | MBX | MBX Biosciences, Inc. | 1.65B | 0.03% | 940,815 | - |
| 116 | TYRA | Tyra Biosciences, Inc. | 1.64B | -4.70% | 982,990 | - |
| 117 | IMCR | Immunocore Holdings plc | 1.64B | -1.36% | 757,500 | 379.59M |
| 118 | OCS | Oculis Holding AG | 1.64B | 0.74% | 444,870 | 992.00K |
| 119 | CLDX | Celldex Therapeutics, Inc. | 1.63B | -0.36% | 558,389 | 2.60M |
| 120 | GLUE | Monte Rosa Therapeutics, Inc. | 1.63B | -3.93% | 1,532,330 | 181.54M |
| 121 | AGIO | Agios Pharmaceuticals, Inc. | 1.60B | -0.62% | 553,239 | 44.79M |
| 122 | PGEN | Precigen, Inc. | 1.59B | -0.88% | 3,456,197 | 6.31M |
| 123 | ELVN | Enliven Therapeutics, Inc. | 1.57B | 3.00% | 1,672,942 | - |
| 124 | BHVN | Biohaven Ltd. | 1.57B | -2.23% | 1,810,284 | - |
| 125 | TNGX | Tango Therapeutics, Inc. | 1.56B | -0.51% | 1,435,878 | 66.50M |
| 126 | FTRE | Fortrea Holdings Inc. | 1.55B | -1.41% | 962,244 | 2.76B |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.52B | -5.40% | 5,298,032 | 57.53M |
| 128 | INVA | Innoviva, Inc. | 1.50B | 1.27% | 836,860 | 388.52M |
| 129 | NVAX | Novavax, Inc. | 1.44B | -6.30% | 5,015,978 | 1.06B |
| 130 | QURE | uniQure N.V. | 1.42B | -3.97% | 1,604,522 | 15.75M |
| 131 | KOD | Kodiak Sciences Inc. | 1.41B | -10.46% | 1,136,277 | - |
| 132 | PHAR | Pharming Group N.V. | 1.39B | -1.06% | 30,173 | 362.27M |
| 133 | ATAI | AtaiBeckley Inc. | 1.37B | -2.08% | 2,136,087 | 3.02M |
| 134 | TRVI | Trevi Therapeutics, Inc. | 1.34B | -2.06% | 1,287,543 | - |
| 135 | DBVT | DBV Technologies S.A. | 1.33B | -5.88% | 395,619 | 5.50M |
| 136 | RLAY | Relay Therapeutics, Inc. | 1.33B | -0.65% | 1,259,048 | 8.36M |
| 137 | ANAB | AnaptysBio, Inc. | 1.31B | -0.92% | 453,729 | 169.47M |
| 138 | SVRA | Savara Inc. | 1.30B | -3.23% | 1,189,060 | - |
| 139 | IMTX | Immatics N.V. | 1.28B | 1.81% | 567,368 | 99.45M |
| 140 | RAPP | Rapport Therapeutics, Inc. | 1.27B | -0.52% | 319,972 | - |
| 141 | TSHA | Taysha Gene Therapies, Inc. | 1.24B | -1.31% | 2,386,950 | 6.31M |
| 142 | XERS | Xeris Biopharma Holdings, Inc. | 1.22B | 1.66% | 1,491,232 | 266.14M |
| 143 | SANA | Sana Biotechnology, Inc. | 1.18B | -3.70% | 2,221,230 | - |
| 144 | DAWN | Day One Biopharmaceuticals, Inc. | 1.15B | - | 1,555,872 | 133.67M |
| 145 | CMPX | Compass Therapeutics, Inc. | 1.14B | 0.31% | 2,838,908 | 850.00K |
| 146 | IVA | Inventiva S.A. | 1.13B | -2.53% | 519,422 | 19.93M |
| 147 | CAPR | Capricor Therapeutics, Inc. | 1.13B | -3.18% | 972,868 | 11.13M |
| 148 | EYPT | EyePoint, Inc. | 1.12B | -8.34% | 1,313,643 | 42.34M |
| 149 | MLTX | MoonLake Immunotherapeutics | 1.12B | -3.33% | 1,161,089 | - |
| 150 | INBX | Inhibrx Biosciences, Inc. | 1.11B | 5.26% | 291,691 | 1.40M |
| 151 | ABCL | AbCellera Biologics Inc. | 1.08B | -6.22% | 4,313,741 | 35.33M |
| 152 | PHAT | Phathom Pharmaceuticals, Inc. | 1.07B | 1.03% | 924,594 | 147.19M |
| 153 | AKTS | Aktis Oncology, Inc. | 1.06B | 3.11% | 162,870 | 5.56M |
| 154 | SEPN | Septerna, Inc. | 1.05B | -1.93% | 282,417 | 22.05M |
| 155 | VIR | Vir Biotechnology, Inc. | 1.04B | -4.37% | 1,904,468 | 16.86M |
| 156 | IOVA | Iovance Biotherapeutics, Inc. | 1.01B | -3.04% | 9,051,778 | 250.43M |
| 157 | NBTX | Nanobiotix S.A. | 1.00B | -4.07% | 11,259 | 11.93M |
| 158 | VTYX | Ventyx Biosciences, Inc. | 1.00B | - | 1,014,606 | - |
| 159 | ORIC | ORIC Pharmaceuticals, Inc. | 999.21M | -4.65% | 1,535,797 | - |
| 160 | SPRY | ARS Pharmaceuticals, Inc. | 987.50M | -2.25% | 1,763,437 | 142.77M |
| 161 | ZBIO | Zenas BioPharma, Inc. | 986.09M | -12.02% | 483,405 | 15.00M |
| 162 | GHRS | GH Research PLC | 971.38M | -3.57% | 127,865 | - |
| 163 | CTMX | CytomX Therapeutics, Inc. | 964.09M | -0.87% | 2,082,512 | 113.63M |
| 164 | TBPH | Theravance Biopharma, Inc. | 959.74M | -1.25% | 328,892 | 80.33M |
| 165 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 937.47M | -6.24% | 158,736 | - |
| 166 | ANNX | Annexon, Inc. | 930.11M | -4.29% | 1,841,321 | - |
| 167 | AVBP | ArriVent BioPharma, Inc. | 928.42M | -0.04% | 473,982 | - |
| 168 | BCAX | Bicara Therapeutics Inc. | 920.34M | -0.65% | 297,445 | - |
| 169 | URGN | UroGen Pharma Ltd. | 917.92M | -5.22% | 648,987 | 96.52M |
| 170 | PVLA | Palvella Therapeutics, Inc. | 907.74M | -6.23% | 556,251 | - |
| 171 | GERN | Geron Corporation | 874.55M | - | 9,625,073 | 183.40M |
| 172 | XNCR | Xencor, Inc. | 863.35M | -2.34% | 565,381 | 150.13M |
| 173 | ARVN | Arvinas, Inc. | 859.32M | - | 1,091,730 | 312.30M |
| 174 | MRVI | Maravai LifeSciences Holdings, Inc. | 859.17M | -2.04% | 1,450,308 | 192.44M |
| 175 | YDES | YD Bio Limited | 834.70M | 7.62% | 34,967 | 510.36K |
| 176 | OMER | Omeros Corporation | 828.83M | -2.18% | 1,379,375 | - |
| 177 | JANX | Janux Therapeutics, Inc. | 824.63M | -0.87% | 1,087,869 | 10.00M |
| 178 | VALN | Valneva SE | 801.04M | -2.13% | 3,115 | 211.09M |
| 179 | ABUS | Arbutus Biopharma Corporation | 794.30M | - | 882,369 | 14.61M |
| 180 | KALV | KalVista Pharmaceuticals, Inc. | 789.03M | -0.26% | 553,190 | 1.43M |
| 181 | MPLT | MapLight Therapeutics, Inc. | 772.02M | -4.79% | 259,634 | - |
| 182 | DRUG | Bright Minds Biosciences Inc. | 771.09M | -5.73% | 197,133 | - |
| 183 | NKTR | Nektar Therapeutics | 759.35M | 5.96% | 995,174 | 62.60M |
| 184 | MDXG | MiMedx Group, Inc. | 756.80M | -0.58% | 1,017,273 | 393.44M |
| 185 | GYRE | Gyre Therapeutics, Inc. | 735.30M | -1.46% | 91,808 | 107.27M |
| 186 | JBIO | Jade Biosciences, Inc. | 718.13M | 1.50% | 488,544 | - |
| 187 | FULC | Fulcrum Therapeutics, Inc. | 707.86M | -1.92% | 491,884 | 80.00M |
| 188 | KURA | Kura Oncology, Inc. | 706.58M | -1.22% | 1,396,886 | 104.03M |
| 189 | CGEM | Cullinan Therapeutics, Inc. | 706.55M | 0.34% | 730,357 | - |
| 190 | PRME | Prime Medicine, Inc. | 674.52M | -8.19% | 3,745,908 | 5.98M |
| 191 | SLS | SELLAS Life Sciences Group, Inc. | 641.96M | -3.08% | 5,412,341 | - |
| 192 | ENGN | enGene Holdings Inc. | 638.36M | -7.21% | 302,542 | - |
| 193 | RIGL | Rigel Pharmaceuticals, Inc. | 632.76M | -0.85% | 246,094 | 282.08M |
| 194 | MGTX | MeiraGTx Holdings plc | 612.54M | -1.68% | 336,452 | 27.42M |
| 195 | CRMD | CorMedix Inc. | 611.40M | -3.24% | 2,356,760 | 214.30M |
| 196 | ALT | Altimmune, Inc. | 611.27M | 9.80% | 6,280,832 | 20.00K |
| 197 | PROK | ProKidney Corp. | 595.65M | -7.04% | 1,628,186 | 744.00K |
| 198 | DRTS | Alpha Tau Medical Ltd. | 591.73M | -4.14% | 314,851 | - |
| 199 | DSGN | Design Therapeutics, Inc. | 581.60M | -3.41% | 392,559 | - |
| 200 | EVMN | Evommune, Inc. | 570.59M | -16.40% | 509,163 | 13.00M |
| 201 | RGNX | REGENXBIO Inc. | 564.95M | -3.79% | 1,010,007 | 161.32M |
| 202 | REPL | Replimune Group, Inc. | 551.46M | -4.87% | 1,157,160 | - |
| 203 | KROS | Keros Therapeutics, Inc. | 545.65M | -0.39% | 214,226 | 246.72M |
| 204 | LBRX | LB Pharmaceuticals Inc | 542.67M | 1.32% | 157,284 | - |
| 205 | LXEO | Lexeo Therapeutics, Inc. | 540.84M | -2.11% | 881,519 | - |
| 206 | GOSS | Gossamer Bio, Inc. | 527.72M | -5.79% | 4,638,149 | 44.05M |
| 207 | FBRX | Forte Biosciences, Inc. | 521.93M | 0.17% | 215,740 | - |
| 208 | CTNM | Contineum Therapeutics, Inc. | 520.91M | -2.33% | 555,275 | - |
| 209 | LYEL | Lyell Immunopharma, Inc. | 509.85M | -3.04% | 75,383 | 41.00K |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 509.82M | -3.65% | 768,822 | 180.61M |
| 211 | TENX | Tenax Therapeutics, Inc. | 507.54M | -6.43% | 284,595 | - |
| 212 | ZVRA | Zevra Therapeutics, Inc. | 506.68M | 1.58% | 716,451 | 84.39M |
| 213 | FDMT | 4D Molecular Therapeutics, Inc. | 506.22M | -1.23% | 1,133,740 | 120.00K |
| 214 | VOR | Vor Biopharma Inc. | 503.36M | -7.08% | 1,033,846 | - |
| 215 | SLDB | Solid Biosciences Inc. | 503.30M | -2.12% | 834,213 | - |
| 216 | LENZ | LENZ Therapeutics, Inc. | 495.01M | -11.02% | 1,815,343 | 17.50M |
| 217 | IVVD | Invivyd, Inc. | 490.66M | -5.95% | 3,302,017 | 50.04M |
| 218 | ANRO | Alto Neuroscience, Inc. | 480.91M | 1.04% | 199,311 | - |
| 219 | NAGE | Niagen Bioscience, Inc. | 479.73M | - | 1,433,998 | 124.71M |
| 220 | OCGN | Ocugen, Inc. | 475.44M | -4.61% | 4,409,188 | 5.37M |
| 221 | PRTA | Prothena Corporation plc | 474.24M | -2.76% | 389,946 | 11.79M |
| 222 | VSTM | Verastem, Inc. | 470.81M | -4.84% | 1,482,519 | 13.38M |
| 223 | KYTX | Kyverna Therapeutics, Inc. | 457.61M | -2.44% | 1,226,989 | - |
| 224 | ABSI | Absci Corporation | 449.61M | -1.32% | 3,277,867 | 2.82M |
| 225 | ADCT | ADC Therapeutics SA | 447.20M | -3.99% | 754,484 | 75.21M |
| 226 | VNDA | Vanda Pharmaceuticals Inc. | 445.59M | -3.08% | 781,040 | 212.07M |
| 227 | BCYC | Bicycle Therapeutics plc | 445.34M | -1.53% | 387,601 | 28.34M |
| 228 | VTVT | vTv Therapeutics Inc. | 439.40M | 5.36% | 32,682 | 17.00K |
| 229 | PRTC | PureTech Health plc | 439.00M | -2.20% | 1,467 | 6.39M |
| 230 | DMAC | DiaMedica Therapeutics Inc. | 430.77M | -5.08% | 228,895 | - |
| 231 | LXRX | Lexicon Pharmaceuticals, Inc. | 421.54M | -19.44% | 17,102,726 | 70.86M |
| 232 | EPRX | Eupraxia Pharmaceuticals Inc. | 420.07M | -0.84% | 167,176 | - |
| 233 | AVXL | Anavex Life Sciences Corp. | 419.94M | -4.28% | 1,834,390 | - |
| 234 | GLSI | Greenwich LifeSciences, Inc. | 416.61M | 0.17% | 329,459 | - |
| 235 | ALLO | Allogene Therapeutics, Inc. | 413.50M | 15.72% | 17,155,808 | 22.00K |
| 236 | BNTC | Benitec Biopharma Inc. | 412.44M | -3.41% | 198,797 | - |
| 237 | TRDA | Entrada Therapeutics, Inc. | 410.26M | -1.89% | 230,430 | 61.52M |
| 238 | ASMB | Assembly Biosciences, Inc. | 407.69M | 0.25% | 88,603 | 37.19M |
| 239 | IMMP | Immutep Limited | 407.11M | -8.08% | 370,106 | 3.31M |
| 240 | MNPR | Monopar Therapeutics Inc. | 403.49M | -10.34% | 284,164 | - |
| 241 | ANL | Adlai Nortye Ltd. | 392.25M | 62.79% | 7,668,000 | -1.35M |
| 242 | NBP | NovaBridge Biosciences | 381.61M | -10.05% | 640,327 | - |
| 243 | ACRS | Aclaris Therapeutics, Inc. | 380.29M | 2.33% | 1,145,111 | 15.74M |
| 244 | TARA | Protara Therapeutics, Inc. | 379.40M | 1.14% | 1,047,438 | - |
| 245 | RCKT | Rocket Pharmaceuticals, Inc. | 376.61M | -1.97% | 1,693,882 | - |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 374.34M | - | 208,748 | 65.32M |
| 247 | TECX | Tectonic Therapeutic, Inc. | 374.14M | -3.38% | 217,426 | - |
| 248 | ZURA | Zura Bio Limited | 369.33M | -5.80% | 641,297 | - |
| 249 | AUTL | Autolus Therapeutics plc | 364.62M | -4.20% | 2,078,480 | 51.13M |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 358.64M | -5.73% | 2,792,539 | 10.82M |
| 251 | AURA | Aura Biosciences, Inc. | 355.62M | 2.19% | 214,933 | - |
| 252 | PEPG | PepGen Inc. | 352.68M | -1.72% | 571,167 | - |
| 253 | NMRA | Neumora Therapeutics, Inc. | 338.18M | -2.93% | 589,624 | - |
| 254 | FHTX | Foghorn Therapeutics Inc. | 334.50M | -1.04% | 159,891 | 24.52M |
| 255 | AVIR | Atea Pharmaceuticals, Inc. | 331.26M | 8.44% | 1,115,771 | - |
| 256 | HELP | Cybin Inc. | 330.36M | -2.22% | 456,922 | - |
| 257 | PBYI | Puma Biotechnology, Inc. | 326.53M | 0.78% | 305,997 | 212.00M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 323.52M | 0.41% | 255,499 | 33.98M |
| 259 | ALDX | Aldeyra Therapeutics, Inc. | 322.47M | 0.75% | 742,803 | - |
| 260 | CADL | Candel Therapeutics, Inc. | 320.61M | -1.52% | 560,226 | - |
| 261 | XOMA | XOMA Royalty Corporation | 317.75M | 2.76% | 274,454 | 47.11M |
| 262 | ACIU | AC Immune SA | 315.63M | -6.18% | 250,739 | 5.48M |
| 263 | RZLT | Rezolute, Inc. | 309.71M | 2.77% | 2,445,988 | - |
| 264 | IMMX | Immix Biopharma, Inc. | 307.21M | -2.02% | 864,750 | - |
| 265 | LRMR | Larimar Therapeutics, Inc. | 302.99M | -0.84% | 853,698 | - |
| 266 | IMRX | Immuneering Corporation | 298.96M | -4.93% | 1,046,890 | - |
| 267 | AARD | Aardvark Therapeutics, Inc. | 282.83M | -2.70% | 168,415 | - |
| 268 | AVTX | Avalo Therapeutics, Inc. | 279.73M | -0.92% | 631,797 | 192.00K |
| 269 | CLLS | Cellectis S.A. | 279.26M | -5.01% | 26,466 | 82.55M |
| 270 | ABEO | Abeona Therapeutics Inc. | 275.83M | 0.20% | 672,896 | 400.00K |
| 271 | NGNE | Neurogene Inc. | 273.55M | -6.51% | 143,737 | 925.00K |
| 272 | OABI | OmniAb, Inc. | 262.00M | -2.15% | 734,594 | 21.09M |
| 273 | CHRS | Coherus Oncology, Inc. | 261.08M | -7.30% | 1,924,090 | 277.73M |
| 274 | RLMD | Relmada Therapeutics, Inc. | 260.33M | -9.21% | 381,716 | - |
| 275 | FENC | Fennec Pharmaceuticals Inc. | 259.23M | 0.93% | 132,079 | 38.79M |
| 276 | CABA | Cabaletta Bio, Inc. | 247.40M | -6.55% | 2,568,450 | - |
| 277 | NAUT | Nautilus Biotechnology, Inc. | 246.29M | 0.52% | 152,401 | - |
| 278 | STTK | Shattuck Labs, Inc. | 244.89M | -4.91% | 579,697 | 1.00M |
| 279 | ARMP | Armata Pharmaceuticals, Inc. | 243.93M | 0.90% | 60,004 | 5.05M |
| 280 | HRTX | Heron Therapeutics, Inc. | 242.04M | -1.49% | 691,396 | 155.10M |
| 281 | CNTX | Context Therapeutics Inc. | 239.80M | 5.67% | 4,282,357 | - |
| 282 | ENLV | Enlivex Therapeutics Ltd. | 239.76M | -2.88% | 356,812 | - |
| 283 | NBY | NovaBay Pharmaceuticals, Inc. | 234.68M | 0.54% | 1,363,023 | 10.30M |
| 284 | MDWD | MediWound Ltd. | 232.45M | 2.95% | 163,977 | 20.93M |
| 285 | SLN | Silence Therapeutics plc | 227.67M | -2.82% | 159,712 | 25.83M |
| 286 | ACHV | Achieve Life Sciences, Inc. | 222.52M | -3.69% | 769,217 | - |
| 287 | PALI | Palisade Bio, Inc. | 222.01M | -7.45% | 6,548,095 | - |
| 288 | VYGR | Voyager Therapeutics, Inc. | 216.84M | -2.01% | 1,017,189 | 31.32M |
| 289 | TNXP | Tonix Pharmaceuticals Holding Corp. | 213.63M | -5.38% | 543,000 | 10.30M |
| 290 | CLYM | Climb Bio, Inc. | 213.42M | -6.49% | 469,318 | - |
| 291 | ARCT | Arcturus Therapeutics Holdings Inc. | 212.25M | -1.32% | 469,073 | 97.60M |
| 292 | SABS | SAB Biotherapeutics, Inc. | 208.99M | -0.68% | 116,997 | 114.70K |
| 293 | NVCT | Nuvectis Pharma, Inc. | 207.74M | -4.81% | 133,421 | - |
| 294 | ALEC | Alector, Inc. | 206.30M | -1.05% | 1,204,455 | 69.05M |
| 295 | IKT | Inhibikase Therapeutics, Inc. | 205.17M | -4.46% | 661,545 | 1.00 |
| 296 | OVID | Ovid Therapeutics Inc. | 203.09M | 0.65% | 1,488,403 | 6.61M |
| 297 | OBIO | Orchestra BioMed Holdings, Inc. | 197.06M | -6.43% | 505,127 | 2.82M |
| 298 | EDIT | Editas Medicine, Inc. | 194.26M | -3.40% | 1,725,506 | 46.38M |
| 299 | MIST | Milestone Pharmaceuticals Inc. | 194.02M | 1.06% | 1,966,512 | - |
| 300 | THAR | Tharimmune, Inc. | 193.30M | 9.40% | 3,568,033 | - |
| 301 | TLSA | Tiziana Life Sciences Ltd | 192.71M | -5.63% | 282,000 | - |
| 302 | HUMA | Humacyte, Inc. | 192.55M | -3.14% | 3,070,497 | 1.57M |
| 303 | CAMP | Camp4 Therapeutics Corporation | 191.96M | -4.39% | 106,561 | 3.80M |
| 304 | PLX | Protalix BioTherapeutics, Inc. | 188.19M | 13.04% | 3,144,319 | 61.84M |
| 305 | CBIO | Crescent Biopharma, Inc. | 187.48M | -5.52% | 198,338 | - |
| 306 | SRZN | Surrozen, Inc. | 184.67M | -2.42% | 79,624 | 3.60M |
| 307 | SGMT | Sagimet Biosciences Inc. | 184.40M | 5.78% | 1,025,469 | - |
| 308 | CCCC | C4 Therapeutics, Inc. | 184.14M | -3.06% | 1,669,983 | 30.11M |
| 309 | GALT | Galectin Therapeutics Inc. | 182.46M | -3.41% | 266,004 | - |
| 310 | MENS | Jyong Biotech Ltd. | 181.48M | -7.81% | 366,139 | - |
| 311 | NTHI | NeOnc Technologies Holdings, Inc. | 180.53M | 5.94% | 277,953 | 59.99K |
| 312 | SGMO | Sangamo Therapeutics, Inc. | 180.19M | 4.39% | 9,691,496 | 32.88M |
| 313 | SLGL | Sol-Gel Technologies Ltd. | 178.90M | 5.54% | 61,739 | 18.97M |
| 314 | RNAC | Cartesian Therapeutics, Inc. | 177.60M | -2.15% | 84,539 | 1.09M |
| 315 | NERV | Minerva Neurosciences, Inc. | 175.69M | -3.33% | 32,274 | - |
| 316 | ELDN | Eledon Pharmaceuticals, Inc. | 174.58M | 2.33% | 534,995 | - |
| 317 | IPHA | Innate Pharma S.A. | 172.33M | 3.39% | 86,007 | 14.84M |
| 318 | CGEN | Compugen Ltd. | 172.11M | -4.66% | 214,995 | 6.90M |
| 319 | PRQR | ProQR Therapeutics N.V. | 170.66M | 1.25% | 443,644 | 18.86M |
| 320 | TNYA | Tenaya Therapeutics, Inc. | 167.73M | -1.94% | 3,488,495 | - |
| 321 | KLRS | Kalaris Therapeutics, Inc. | 166.08M | -3.48% | 43,018 | - |
| 322 | IPSC | Century Therapeutics, Inc. | 166.07M | -5.47% | 1,478,003 | 113.34M |
| 323 | IRD | Opus Genetics, Inc. | 159.31M | -7.60% | 973,576 | 14.63M |
| 324 | MOLN | Molecular Partners AG | 159.11M | 2.41% | 4,344 | 856.30K |
| 325 | NKTX | Nkarta, Inc. | 157.69M | -8.64% | 1,464,251 | - |
| 326 | ABOS | Acumen Pharmaceuticals, Inc. | 157.49M | -6.81% | 700,339 | - |
| 327 | ZNTL | Zentalis Pharmaceuticals, Inc. | 157.34M | -3.19% | 469,471 | 26.87M |
| 328 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 153.23M | -4.17% | 108,774 | - |
| 329 | PRLD | Prelude Therapeutics Incorporated | 152.44M | -2.63% | 142,899 | 10.50M |
| 330 | RANI | Rani Therapeutics Holdings, Inc. | 147.04M | -5.47% | 1,301,012 | 1.20M |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 141.87M | -5.32% | 805,493 | 70.00M |
| 332 | FATE | Fate Therapeutics, Inc. | 137.27M | - | 1,593,338 | 7.14M |
| 333 | CNTB | Connect Biopharma Holdings Limited | 135.29M | -5.10% | 80,558 | 762.00K |
| 334 | MCRB | Seres Therapeutics, Inc. | 134.97M | -2.36% | 48,846 | 351.00K |
| 335 | ORMP | Oramed Pharmaceuticals Inc. | 134.13M | -1.46% | 140,442 | 2.00M |
| 336 | ELTX | Elicio Therapeutics, Inc. | 132.81M | -3.84% | 121,234 | - |
| 337 | CRBU | Caribou Biosciences, Inc. | 131.79M | -4.73% | 790,198 | 9.30M |
| 338 | VXRT | Vaxart, Inc. | 131.21M | -10.22% | - | 148.20M |
| 339 | ADAG | Adagene Inc. | 129.61M | -5.50% | 182,453 | 103.20K |
| 340 | UNCY | Unicycive Therapeutics, Inc. | 128.30M | -10.49% | 1,807,239 | - |
| 341 | STRO | Sutro Biopharma, Inc. | 127.36M | 0.20% | 93,524 | 105.65M |
| 342 | WHWK | Whitehawk Therapeutics, Inc. | 127.25M | 0.37% | 65,673 | 14.38M |
| 343 | KRRO | Korro Bio, Inc. | 125.53M | 0.15% | 374,164 | 7.37M |
| 344 | SPRO | Spero Therapeutics, Inc. | 123.38M | -2.67% | 244,496 | 40.55M |
| 345 | TTRX | Turn Therapeutics Inc. | 121.31M | -5.29% | 54,780 | - |
| 346 | KPTI | Karyopharm Therapeutics Inc. | 119.38M | -1.66% | 267,901 | 142.53M |
| 347 | CRDF | Cardiff Oncology, Inc. | 117.88M | 8.36% | 2,205,370 | 501.00K |
| 348 | GNLX | Genelux Corporation | 117.80M | -2.92% | 148,360 | 8.00K |
| 349 | MGNX | MacroGenics, Inc. | 115.76M | -5.18% | 1,027,511 | 127.63M |
| 350 | VRCA | Verrica Pharmaceuticals Inc. | 112.41M | -2.50% | 127,605 | 30.83M |
| 351 | CDXS | Codexis, Inc. | 112.00M | -4.62% | 1,078,721 | 52.93M |
| 352 | INO | Inovio Pharmaceuticals, Inc. | 111.99M | 1.24% | 992,422 | 182.34K |
| 353 | VANI | Vivani Medical, Inc. | 111.00M | -7.95% | 606,963 | - |
| 354 | ACTU | Actuate Therapeutics, Inc. | 109.48M | -0.63% | 60,863 | - |
| 355 | CBUS | Cibus, Inc. | 105.73M | 1.56% | 488,807 | 3.79M |
| 356 | ONCY | Oncolytics Biotech Inc. | 105.53M | -2.90% | 1,242,707 | - |
| 357 | ACOG | Alpha Cognition Inc. | 105.23M | -6.56% | 18,853 | 7.43M |
| 358 | SEER | Seer, Inc. | 102.38M | -2.15% | 137,110 | 16.38M |
| 359 | CSBR | Champions Oncology, Inc. | 101.51M | 0.82% | 3,938 | 58.42M |
| 360 | ANIX | Anixa Biosciences, Inc. | 101.47M | -1.94% | 175,350 | - |
| 361 | COYA | Coya Therapeutics, Inc. | 97.30M | 1.09% | 292,996 | 3.99M |
| 362 | AGEN | Agenus Inc. | 96.58M | -5.02% | 533,065 | 106.83M |
| 363 | CGTX | Cognition Therapeutics, Inc. | 96.22M | -12.10% | 2,083,284 | - |
| 364 | FBIO | Fortress Biotech, Inc. | 96.22M | -7.74% | 821,417 | 62.30M |
| 365 | SAVA | Cassava Sciences, Inc. | 96.13M | -2.45% | 783,077 | - |
| 366 | ARTV | Artiva Biotherapeutics, Inc. | 95.48M | -6.27% | 338,696 | 251.00K |
| 367 | DTIL | Precision BioSciences, Inc. | 95.32M | -0.63% | 225,079 | 698.00K |
| 368 | ALXO | ALX Oncology Holdings Inc. | 94.34M | 10.83% | 2,238,343 | - |
| 369 | MAIA | MAIA Biotechnology, Inc. | 92.22M | 0.84% | 541,702 | - |
| 370 | PYXS | Pyxis Oncology, Inc. | 90.28M | -7.05% | 389,355 | 2.82M |
| 371 | DWTX | Dogwood Therapeutics, Inc. | 89.51M | -3.79% | 52,972 | - |
| 372 | ATYR | aTyr Pharma, Inc. | 86.50M | 3.79% | 3,124,802 | 190.00K |
| 373 | EQ | Equillium, Inc. | 86.47M | 2.90% | 1,022,752 | 4.39M |
| 374 | EXOZ | eXoZymes, Inc. | 86.10M | 0.59% | 3,979 | -700.00 |
| 375 | MNOV | MediciNova, Inc. | 84.53M | -1.71% | 61,979 | 257.92K |
| 376 | SPRB | Spruce Biosciences, Inc. | 83.01M | -2.89% | 15,033 | 697.00K |
| 377 | ETHZ | ETHZilla Corporation | 81.56M | -7.54% | 695,043 | 4.11M |
| 378 | ACET | Adicet Bio, Inc. | 80.75M | -6.00% | 170,778 | - |
| 379 | IMA | ImageneBio, Inc. | 79.99M | 2.46% | 88,503 | 800.00K |
| 380 | BMEA | Biomea Fusion, Inc. | 79.19M | -5.08% | 1,230,627 | - |
| 381 | COEP | Coeptis Therapeutics Holdings, Inc. | 78.73M | 1.84% | 46,321 | 501.00K |
| 382 | OKYO | OKYO Pharma Limited | 77.10M | 0.49% | 285,936 | - |
| 383 | XBIT | XBiotech Inc. | 76.52M | -1.18% | 9,074 | - |
| 384 | PYPD | PolyPid Ltd. | 76.19M | -2.76% | 43,298 | - |
| 385 | HYFT | MindWalk Holdings Corp. | 75.64M | -10.00% | 853,857 | 19.02M |
| 386 | IMUX | Immunic, Inc. | 75.18M | 2.46% | 1,109,043 | - |
| 387 | PLRX | Pliant Therapeutics, Inc. | 74.35M | -2.42% | 1,088,767 | - |
| 388 | PTHS | Pelthos Therapeutics Inc. | 74.14M | -6.83% | 8,161 | 7.41M |
| 389 | ATOS | Atossa Therapeutics, Inc. | 72.98M | -5.83% | 2,840,886 | - |
| 390 | ANVS | Annovis Bio, Inc. | 71.56M | -3.91% | 534,145 | - |
| 391 | GUTS | Fractyl Health, Inc. | 70.55M | -21.35% | 37,004,333 | 3.00K |
| 392 | MREO | Mereo BioPharma Group plc | 70.02M | - | 7,443,928 | 500.00K |
| 393 | GANX | Gain Therapeutics, Inc. | 69.23M | -6.25% | 511,611 | - |
| 394 | KZIA | Kazia Therapeutics Limited | 63.85M | -3.93% | 293,981 | 1.20M |
| 395 | BYSI | BeyondSpring Inc. | 63.33M | -1.28% | 20,379 | 1.88M |
| 396 | ENTX | Entera Bio Ltd. | 62.82M | -6.16% | 159,311 | 124.00K |
| 397 | NRXP | NRx Pharmaceuticals, Inc. | 62.17M | -0.94% | 380,656 | 242.00K |
| 398 | TVGN | Tevogen Bio Holdings Inc. | 61.17M | 1.74% | 3,998,531 | - |
| 399 | IFRX | InflaRx N.V. | 59.76M | -4.40% | 255,669 | 73.73K |
| 400 | NTRB | Nutriband Inc. | 58.23M | 5.97% | 13,664 | 2.28M |
| 401 | TCRX | TScan Therapeutics, Inc. | 57.88M | -1.92% | 507,910 | 8.42M |
| 402 | MGX | Metagenomi Therapeutics, Inc. | 57.82M | -2.53% | 196,475 | 30.91M |
| 403 | PMVP | PMV Pharmaceuticals, Inc. | 57.47M | -3.57% | 195,806 | - |
| 404 | ACRV | Acrivon Therapeutics, Inc. | 56.48M | -4.79% | 625,551 | - |
| 405 | GRCE | Grace Therapeutics, Inc. | 56.17M | 3.42% | 73,783 | - |
| 406 | INKT | MiNK Therapeutics, Inc. | 55.30M | -3.84% | 19,972 | - |
| 407 | ICCC | ImmuCell Corporation | 54.46M | -0.33% | 8,934 | 27.77M |
| 408 | ATHE | Alterity Therapeutics Limited | 53.24M | -2.76% | 14,515 | 3.57M |
| 409 | RADX | Radiopharm Theranostics Limited | 52.05M | 1.41% | 35,727 | 8.20M |
| 410 | IBO | Impact BioMedical Inc. | 51.26M | 2.94% | 82,733 | 25.00K |
| 411 | LPCN | Lipocine Inc. | 49.97M | 0.11% | 104,602 | 4.32M |
| 412 | ALGS | Aligos Therapeutics, Inc. | 49.66M | -0.62% | 40,148 | 2.65M |
| 413 | CVM | CEL-SCI Corporation | 48.77M | -1.19% | 82,770 | - |
| 414 | OSTX | OS Therapies Incorporated | 47.89M | -1.45% | 418,379 | - |
| 415 | TIL | Instil Bio, Inc. | 47.88M | -1.53% | 36,157 | - |
| 416 | QTTB | Q32 Bio Inc. | 47.74M | -3.48% | 179,523 | - |
| 417 | CRVO | CervoMed Inc. | 47.65M | -0.39% | 86,427 | 6.16M |
| 418 | ABVC | ABVC BioPharma, Inc. | 47.61M | -2.88% | 56,238 | 797.92K |
| 419 | IBIO | iBio, Inc. | 47.22M | -2.33% | 1,151,783 | 500.00K |
| 420 | ESLA | Estrella Immunopharma, Inc. | 47.08M | 3.70% | 76,356 | - |
| 421 | PDSB | PDS Biotechnology Corporation | 45.57M | -4.51% | 394,224 | - |
| 422 | NRXS | NeurAxis, Inc. | 45.06M | -9.03% | 204,488 | 3.36M |
| 423 | LITS | Lite Strategy, Inc. | 44.49M | -3.20% | 290,181 | - |
| 424 | KZR | Kezar Life Sciences, Inc. | 44.45M | -1.62% | 28,747 | - |
| 425 | LONA | LeonaBio, Inc. | 44.25M | 0.64% | 50,082 | - |
| 426 | ANEB | Anebulo Pharmaceuticals, Inc. | 43.14M | 20.00% | 173,287 | - |
| 427 | INMB | INmune Bio Inc. | 42.27M | 1.92% | 178,982 | 50.00K |
| 428 | GLTO | Galecto, Inc. | 41.91M | 4.52% | 46,920 | - |
| 429 | JSPR | Jasper Therapeutics, Inc. | 41.42M | -4.52% | 358,837 | - |
| 430 | CING | Cingulate Inc. | 41.24M | 0.35% | 190,186 | - |
| 431 | LSTA | Lisata Therapeutics, Inc. | 40.84M | -0.22% | 77,680 | 1.07M |
| 432 | VERU | Veru Inc. | 40.61M | -3.07% | 78,113 | 16.89M |
| 433 | PSTV | Plus Therapeutics, Inc. | 40.35M | -6.94% | 10,368,339 | 5.26M |
| 434 | XLO | Xilio Therapeutics, Inc. | 40.18M | -2.46% | 524,792 | 31.80M |
| 435 | APLM | Apollomics, Inc. | 39.27M | 2.12% | 3,451 | 6.93M |
| 436 | TELO | Telomir Pharmaceuticals, Inc. | 39.19M | -6.56% | 472,348 | - |
| 437 | RNXT | RenovoRx, Inc. | 38.12M | 8.33% | 367,332 | 928.00K |
| 438 | NXTC | NextCure, Inc. | 38.04M | 4.13% | 29,222 | - |
| 439 | GBIO | Generation Bio Co. | 37.73M | -0.36% | 74,417 | 15.27M |
| 440 | ATRA | Atara Biotherapeutics, Inc. | 37.49M | -5.63% | 202,311 | 151.93M |
| 441 | TVRD | Tvardi Therapeutics, Inc. | 37.24M | 1.79% | 58,914 | - |
| 442 | PASG | Passage Bio, Inc. | 36.56M | 7.18% | 46,615 | - |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 36.19M | -5.69% | 108,178 | 90.00K |
| 444 | OKUR | OnKure Therapeutics, Inc. | 35.77M | -3.30% | 69,927 | - |
| 445 | LTRN | Lantern Pharma Inc. | 35.23M | 1.29% | 93,923 | - |
| 446 | CELU | Celularity Inc. | 35.18M | -3.71% | 54,836 | 40.58M |
| 447 | PLUR | Pluri Inc. | 34.72M | 4.82% | 8,142 | 1.33M |
| 448 | SER | Serina Therapeutics, Inc. | 34.66M | -8.19% | 1,671,338 | 116.00K |
| 449 | RNTX | Rein Therapeutics Inc. | 34.17M | -9.09% | 135,102 | - |
| 450 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 34.17M | -2.11% | 2,096,976 | - |
| 451 | HURA | TuHURA Biosciences, Inc. | 32.49M | -4.62% | 293,266 | - |
| 452 | LIXT | Lixte Biotechnology Holdings, Inc. | 32.41M | -4.86% | 175,113 | - |
| 453 | SKYE | Skye Bioscience, Inc. | 32.38M | 5.21% | 202,211 | - |
| 454 | OTLK | Outlook Therapeutics, Inc. | 32.32M | -4.39% | 1,512,978 | 1.41M |
| 455 | HOWL | Werewolf Therapeutics, Inc. | 32.11M | -8.69% | 479,981 | 1.14M |
| 456 | KYNB | Kyntra Bio, Inc. | 31.88M | -1.62% | 49,302 | 8.30M |
| 457 | DYAI | Dyadic International, Inc. | 31.52M | -3.76% | 40,113 | 3.34M |
| 458 | ANTX | AN2 Therapeutics, Inc. | 30.96M | - | 32,204 | - |
| 459 | CUE | Cue Biopharma, Inc. | 30.55M | -7.33% | 723,402 | 7.10M |
| 460 | PMN | ProMIS Neurosciences, Inc. | 30.48M | 17.90% | 7,933,525 | - |
| 461 | NRSN | NeuroSense Therapeutics Ltd. | 30.46M | -3.15% | 147,692 | - |
| 462 | BRNS | Barinthus Biotherapeutics plc | 29.81M | 1.19% | 3,393 | 14.97M |
| 463 | HYPD | Hyperion DeFi, Inc. | 29.56M | -3.83% | 224,587 | 345.32K |
| 464 | AEON | AEON Biopharma, Inc. | 27.87M | -2.52% | 93,132 | - |
| 465 | RLYB | Rallybio Corporation | 27.12M | -3.86% | 180,422 | 674.00K |
| 466 | PTN | Palatin Technologies, Inc. | 26.97M | -1.74% | 21,608 | 8.85M |
| 467 | BCTX | BriaCell Therapeutics Corp. | 26.93M | -0.23% | 246,099 | - |
| 468 | MRKR | Marker Therapeutics, Inc. | 26.68M | -0.62% | 163,798 | 4.69M |
| 469 | EVAX | Evaxion A/S | 26.52M | -6.47% | 76,707 | 7.65M |
| 470 | SNTI | Senti Biosciences, Inc. | 26.29M | -1.96% | 221,006 | - |
| 471 | BOLD | Boundless Bio, Inc. | 25.97M | -1.69% | 122,302 | - |
| 472 | XCUR | Exicure, Inc. | 25.94M | -4.46% | 14,065 | 500.00K |
| 473 | IGC | IGC Pharma, Inc. | 25.87M | -2.63% | 354,484 | 1.11M |
| 474 | DARE | Daré Bioscience, Inc. | 25.86M | -4.74% | 186,803 | -57.13K |
| 475 | CLGN | CollPlant Biotechnologies Ltd. | 24.15M | -0.84% | 13,975 | 2.48M |
| 476 | GNTA | Genenta Science S.p.A. | 23.11M | -15.69% | 328,692 | - |
| 477 | FBLG | FibroBiologics, Inc. | 22.07M | -2.75% | 519,055 | - |
| 478 | VTGN | Vistagen Therapeutics, Inc. | 22.05M | 3.14% | 712,374 | 721.00K |
| 479 | INTS | Intensity Therapeutics, Inc. | 21.96M | -2.53% | 918,353 | - |
| 480 | NEUP | Neuphoria Therapeutics Inc. | 21.62M | - | 21,689 | 15.65M |
| 481 | CASI | CASI Pharmaceuticals, Inc. | 20.96M | 3.02% | 52,007 | 26.85M |
| 482 | IOBT | IO Biotech, Inc. | 20.87M | -8.28% | 1,686,286 | - |
| 483 | NNVC | NanoViricides, Inc. | 20.81M | -3.50% | 202,647 | - |
| 484 | KLTO | Klotho Neurosciences, Inc. | 19.94M | -2.24% | 1,088,096 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 19.88M | 0.12% | 131,088 | - |
| 486 | LEXX | Lexaria Bioscience Corp. | 19.50M | 3.68% | 163,024 | 522.00K |
| 487 | INAB | IN8bio, Inc. | 19.24M | -1.50% | 36,326 | - |
| 488 | VYNE | VYNE Therapeutics Inc. | 18.84M | -0.07% | 905,194 | 524.00K |
| 489 | PLRZ | Polyrizon Ltd. | 18.35M | -12.27% | 56,813 | - |
| 490 | LNAI | Lunai Bioworks Inc. | 18.29M | -7.11% | 42,172 | - |
| 491 | JUNS | Jupiter Neurosciences, Inc. | 18.17M | -12.03% | 454,362 | - |
| 492 | QNTM | Quantum BioPharma Ltd. | 17.95M | -5.95% | 48,519 | - |
| 493 | ALLR | Allarity Therapeutics, Inc. | 17.36M | -4.31% | 235,500 | - |
| 494 | BCAB | BioAtla, Inc. | 17.07M | -6.60% | 2,330,478 | 11.00M |
| 495 | TRAW | Traws Pharma, Inc. | 16.86M | 0.48% | 178,622 | 2.85M |
| 496 | CVKD | Cadrenal Therapeutics, Inc. | 16.25M | -6.84% | 41,469 | - |
| 497 | ITRM | Iterum Therapeutics plc | 16.22M | -1.98% | 254,685 | 390.00K |
| 498 | APLT | Applied Therapeutics, Inc. | 15.67M | 7.64% | 4,244,929 | 1.00M |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 15.37M | -3.88% | 265,237 | - |
| 500 | OSRH | OSR Holdings, Inc. | 14.99M | -9.46% | 556,227 | -90.52K |
| 501 | KALA | KALA BIO, Inc. | 14.97M | -1.85% | 522,360 | - |
| 502 | LIMN | Liminatus Pharma, Inc. | 14.89M | -6.79% | 76,638 | - |
| 503 | KAPA | Kairos Pharma, Ltd. | 13.83M | -0.06% | 126,042 | - |
| 504 | HOTH | Hoth Therapeutics, Inc. | 13.78M | -2.93% | 202,234 | - |
| 505 | CLRB | Cellectar Biosciences, Inc. | 13.65M | -0.62% | 39,176 | - |
| 506 | COCP | Cocrystal Pharma, Inc. | 13.51M | -1.98% | 62,409 | - |
| 507 | TPST | Tempest Therapeutics, Inc. | 13.40M | 93.59% | 88,618 | - |
| 508 | MBRX | Moleculin Biotech, Inc. | 13.21M | 0.23% | 37,218 | - |
| 509 | BCDA | BioCardia, Inc. | 13.05M | -2.38% | 58,413 | 3.00K |
| 510 | CALC | CalciMedica, Inc. | 12.97M | -11.76% | 2,063,433 | - |
| 511 | BLRX | BioLineRx Ltd. | 12.64M | -1.89% | 12,265 | 12.74M |
| 512 | SNGX | Soligenix, Inc. | 12.61M | -4.58% | 265,330 | 2.34K |
| 513 | SNSE | Sensei Biotherapeutics, Inc. | 11.98M | -1.66% | 69,087 | - |
| 514 | LGVN | Longeveron Inc. | 11.94M | -3.47% | 158,647 | 1.44M |
| 515 | NCEL | NewcelX Ltd. | 11.85M | 1.96% | 65,461 | - |
| 516 | CRIS | Curis, Inc. | 11.61M | -1.39% | 149,530 | 11.65M |
| 517 | BOLT | Bolt Biotherapeutics, Inc. | 11.32M | -5.60% | 31,361 | 5.20M |
| 518 | IMNN | Imunon, Inc. | 11.29M | 0.30% | 20,498 | - |
| 519 | PHIO | Phio Pharmaceuticals Corp. | 10.87M | -0.98% | 238,482 | - |
| 520 | AKTX | Akari Therapeutics, Plc | 10.62M | 1.34% | 104,424 | - |
| 521 | GRDX | GridAI Technologies Corp. | 10.52M | 9.82% | 213,324 | - |
| 522 | NCNA | NuCana plc | 10.45M | -7.38% | 91,753 | - |
| 523 | BRTX | BioRestorative Therapies, Inc. | 10.12M | - | 20,256 | 383.40K |
| 524 | EDSA | Edesa Biotech, Inc. | 9.75M | -4.88% | 272,726 | - |
| 525 | REVB | Revelation Biosciences, Inc. | 9.64M | - | 426,338 | - |
| 526 | ERNA | Ernexa Therapeutics Inc. | 9.58M | 1.67% | 33,203 | 1,000.00 |
| 527 | CMMB | Chemomab Therapeutics Ltd. | 9.54M | -1.27% | 22,134 | - |
| 528 | QNCX | Quince Therapeutics, Inc. | 9.47M | -37.06% | 34,017,042 | - |
| 529 | PULM | Pulmatrix, Inc. | 9.39M | -1.91% | 6,450 | 3.00K |
| 530 | GDTC | CytoMed Therapeutics Limited | 9.31M | -4.12% | 8,089 | 573.19K |
| 531 | EVGN | Evogene Ltd. | 8.96M | - | 10,771 | 8.02M |
| 532 | KPRX | Kiora Pharmaceuticals, Inc. | 8.80M | 4.35% | 144,064 | 20.00K |
| 533 | PHGE | BiomX Inc. | 8.73M | -18.87% | 213,959 | - |
| 534 | RNAZ | TransCode Therapeutics, Inc. | 8.70M | -9.45% | 16,532 | - |
| 535 | BIVI | BioVie Inc. | 8.59M | -8.06% | 157,527 | - |
| 536 | ICU | SeaStar Medical Holding Corporation | 8.58M | 1.93% | 168,437 | 881.00K |
| 537 | PMCB | PharmaCyte Biotech, Inc. | 8.30M | -3.42% | 212,540 | - |
| 538 | XTLB | XTL Biopharmaceuticals Ltd. | 8.25M | 1.73% | 40,521 | 968.00K |
| 539 | ALZN | Alzamend Neuro, Inc. | 8.17M | 6.44% | 59,486 | - |
| 540 | IMRN | Immuron Limited | 7.97M | 2.02% | 30,016 | 4.78M |
| 541 | MTVA | MetaVia Inc. | 7.80M | 2.97% | 410,825 | - |
| 542 | APM | Aptorum Group Limited | 7.71M | 16.24% | 151,468 | - |
| 543 | VIVS | VivoSim Labs, Inc. | 7.62M | 71.76% | 72,374,346 | 140.00K |
| 544 | ADXN | Addex Therapeutics Ltd | 7.53M | -5.83% | 1,747 | 198.82K |
| 545 | CLDI | Calidi Biotherapeutics, Inc. | 7.46M | -2.86% | 90,192 | - |
| 546 | APVO | Aptevo Therapeutics Inc. | 7.25M | -1.62% | 35,280 | - |
| 547 | CELZ | Creative Medical Technology Holdings, Inc. | 7.06M | -4.27% | 35,173 | 6.00K |
| 548 | MBIO | Mustang Bio, Inc. | 7.04M | -0.63% | 35,042 | - |
| 549 | GTBP | GT Biopharma, Inc. | 7.02M | -2.93% | 532,656 | - |
| 550 | PCSA | Processa Pharmaceuticals, Inc. | 6.80M | -4.46% | 34,580 | - |
| 551 | PPBT | Purple Biotech Ltd | 6.62M | -3.17% | 96,947 | - |
| 552 | TOVX | Theriva Biologics, Inc. | 6.42M | -3.49% | 1,995,264 | - |
| 553 | GNPX | Genprex, Inc. | 6.17M | 8.13% | 1,968,163 | - |
| 554 | QNRX | Quoin Pharmaceuticals, Ltd. | 6.05M | -13.07% | 57,627 | - |
| 555 | BGMS | Bio Green Med Solution, Inc. | 5.93M | -1.63% | 21,748 | 81.00K |
| 556 | ADIL | Adial Pharmaceuticals, Inc. | 5.92M | -0.28% | 269,525 | - |
| 557 | TCRT | Alaunos Therapeutics, Inc. | 5.87M | -4.36% | 37,661 | 6.00K |
| 558 | ASBP | Aspire Biopharma Holdings, Inc. | 5.72M | 45.89% | 5,396,285 | 1.94K |
| 559 | SLXN | Silexion Therapeutics Corp | 5.72M | -6.63% | 108,351 | - |
| 560 | CANF | Can-Fite BioPharma Ltd. | 5.68M | -2.20% | 19,015 | 560.00K |
| 561 | APRE | Aprea Therapeutics, Inc. | 5.57M | 34.92% | 109,847,087 | 488.24K |
| 562 | ACXP | Acurx Pharmaceuticals, Inc. | 5.55M | -5.21% | 58,729 | - |
| 563 | DRMA | Dermata Therapeutics, Inc. | 5.37M | -19.93% | 980,478 | - |
| 564 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 5.34M | -14.26% | 185,793 | 1.36M |
| 565 | ABP | Abpro Holdings, Inc. | 5.24M | -1.03% | 34,731 | 183.00K |
| 566 | CYCN | Cyclerion Therapeutics, Inc. | 5.18M | -0.73% | 31,791 | 2.86M |
| 567 | XBIO | Xenetic Biosciences, Inc. | 5.09M | -4.72% | 15,584 | 2.86M |
| 568 | INDP | Indaptus Therapeutics, Inc. | 4.93M | 0.46% | 23,851 | - |
| 569 | DCOY | Decoy Therapeutics Inc. | 4.92M | -7.01% | 164,601 | - |
| 570 | GOVX | GeoVax Labs, Inc. | 4.81M | -1.06% | 95,189 | 3.35M |
| 571 | MLEC | Moolec Science SA | 4.72M | 0.46% | 244,584 | 7.83M |
| 572 | SILO | Silo Pharma, Inc. | 4.60M | 4.93% | 299,748 | 72.10K |
| 573 | ELAB | PMGC Holdings Inc. | 4.16M | 5.41% | 760,705 | 285.95K |
| 574 | PBM | Psyence Biomedical Ltd. | 4.09M | -11.10% | 521,700 | - |
| 575 | ENVB | Enveric Biosciences, Inc. | 4.05M | -5.21% | 56,536 | - |
| 576 | GLMD | Galmed Pharmaceuticals Ltd. | 3.89M | -5.33% | 69,416 | - |
| 577 | MTNB | Matinas BioPharma Holdings, Inc. | 3.83M | -10.12% | 55,361 | - |
| 578 | OGEN | Oragenics, Inc. | 3.59M | 2.39% | 60,000 | - |
| 579 | XRTX | XORTX Therapeutics Inc. | 3.54M | 1.94% | 45,746 | - |
| 580 | CNSP | CNS Pharmaceuticals, Inc. | 3.46M | -3.63% | 33,991 | - |
| 581 | ARTL | Artelo Biosciences, Inc. | 3.45M | 1.79% | 24,578 | - |
| 582 | SCNI | Scinai Immunotherapeutics Ltd. | 3.40M | 1.03% | 27,900 | 1.15M |
| 583 | SPRC | SciSparc Ltd. | 3.35M | -2.66% | 148,345 | 1.31M |
| 584 | CMND | Clearmind Medicine Inc. | 3.25M | -0.91% | 33,648 | - |
| 585 | LYRA | Lyra Therapeutics, Inc. | 3.16M | -12.75% | 27,905 | 600.00K |
| 586 | JAGX | Jaguar Health, Inc. | 3.06M | -2.39% | 341,469 | 11.79M |
| 587 | PPCB | Propanc Biopharma, Inc. | 3.04M | -18.03% | 1,419,999 | - |
| 588 | HCWB | HCW Biologics Inc. | 3.00M | -2.63% | 80,408 | 422.03K |
| 589 | BBLG | Bone Biologics Corporation | 2.94M | -2.38% | 21,576 | - |
| 590 | CDIO | Cardio Diagnostics Holdings, Inc. | 2.76M | -5.63% | 90,129 | 15.78K |
| 591 | ENSC | Ensysce Biosciences, Inc. | 2.64M | 0.86% | 106,197 | 4.49M |
| 592 | AZTR | Azitra, Inc. | 2.63M | -7.74% | 1,531,423 | 7.50K |
| 593 | ONCO | Onconetix, Inc. | 2.21M | -4.70% | 56,727 | 1.22M |
| 594 | VRAX | Virax Biolabs Group Limited | 2.10M | -0.70% | 139,039 | 2.99K |
| 595 | CDT | CDT Equity Inc. | 1.89M | -0.91% | 45,472 | - |
| 596 | GRI | GRI Bio, Inc. | 1.75M | -1.81% | 206,068 | - |
| 597 | BDRX | Biodexa Pharmaceuticals Plc | 1.48M | -3.80% | 133,119 | 104.90K |
| 598 | ADTX | Aditxt, Inc. | 1.45M | -0.48% | 142,567 | 5.95K |